Rankings
▼
Calendar
VTYX Q4 2022 Earnings — Ventyx Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
VTYX
Ventyx Biosciences, Inc.
$1B
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$39M
Net Income
-$35M
EPS (Diluted)
$-0.62
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$47M
Free Cash Flow
-$47M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$371M
Total Liabilities
$18M
Stockholders' Equity
$354M
Cash & Equivalents
$65M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$39M
-$18M
-116.4%
Net Income
-$35M
-$18M
-98.2%
← FY 2022
All Quarters
Q1 2023 →